MGLL and skin disorder: In line with this, the systemic and spinal administration of the MAGL inhibitor JZL184 produced an antipruritic effect in mice [46], and a notable increase of 2-AG levels in skin lesions was observed in mice affected by mite antigen-induced dermatitis compared to controls [47].